Valuation (78%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.86 | N/A |
| PEG Ratio (TTM) | 4.99 | N/A |
| P/S Ratio (TTM) | 1.76 | N/A |
| P/B Ratio (TTM) | 1.13 | N/A |
| P/FCF Ratio (TTM) | 9.43 | N/A |
| Price to 5YR AVG Earnings Ratio | 10.24 | N/A |
| Price to 5YR AVG FCF Ratio | 8.91 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.89% | N/A |
| ROE (TTM) | 10.81% | N/A |
| Net Profit Margin (TTM) | 16.20% | N/A |
| ROIC 5YR AVG | 35.12% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 2.21% | 39.04% | 20.60% |
| Revenue | 10.11% | 16.26% | 11.48% |
| Net Income | 1.52% | 38.54% | 20.58% |
| Cash Flow | 85.22% | -216.76% | -54.63% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 271.31 | N/A |
| Quick Ratio (TTM) | 271.31 | N/A |
| D/E Ratio (TTM) | 0.37 | N/A |
| Interest Coverage (TTM) | 1.44 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 1.43 | N/A |
| LTL to 5YR AVG FCF | 4.41 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.43% | N/A |